Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.
There are no data from proper studies to answer whether it is necessary to include antibiotics that are active against atypical pneumonia agents as part of the empiric therapy of CAP. Until such data are available, clinical judgment and severity of the pneumonic illness are the best guides to empiric antimicrobial therapy.
Marrie
Thomas J
TJ
2J2.00 Walter C. Mackenzie Health Sciences Centre, 8440 112th Street, Edmonton, Alberta T6G 2R7, Canada. tom.marrie@ualberta.ca
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000188:drug therapy; D016993:Chlamydophila pneumoniae; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D007877:Legionnaires' Disease / Q000188:drug therapy; D018410:Pneumonia, Bacterial / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D011019:Pneumonia, Mycoplasma / Q000188:drug therapy; D011778:Q Fever / Q000188:drug therapy
D000900:Anti-Bacterial Agents